Related Experiment Video
Updated: May 3, 2026

09:05
Imaging Metals in Brain Tissue by Laser Ablation - Inductively Coupled Plasma - Mass Spectrometry LA-ICP-MS
Published on: January 22, 2017
23.0K
Mapping complex disease loci in whole-genome association studies
Christopher S Carlson1, Michael A Eberle, Leonid Kruglyak
1Department of Genome Sciences, University of Washington, 1705 NE Pacific, Seattle, Washington 98195-7730, USA. csc47@u.washington.edu
Nature
|May 28, 2004
Summary
Identifying genetic polymorphisms for common diseases like type 2 diabetes and schizophrenia is crucial. Whole-genome association studies offer a promising approach for understanding disease genetics, despite current challenges.
Area of Science:
- Genetics and genomics
- Disease susceptibility research
- Biomedical diagnostics and therapeutics development
Background:
- Genetic polymorphisms play a role in common diseases like type 2 diabetes and schizophrenia.
- Previous research relied on genetic linkage techniques.
- Advancements in technology and resources enable whole-genome association studies.
Purpose of the Study:
- To explore the potential of whole-genome association studies (WGAS) for identifying genetic polymorphisms linked to common diseases.
- To highlight the feasibility of WGAS in dissecting complex disease genetics.
- To address the challenges associated with WGAS.
Main Methods:
- Utilizing new technologies and experimental resources for whole-genome association studies.
- Focusing on identifying genetic polymorphisms associated with disease susceptibility.
- Addressing challenges in study design and statistical analysis.
Main Results:
- Whole-genome association studies are a feasible approach for dissecting the genetics of common diseases.
- Identification of susceptibility polymorphisms can aid in developing diagnostics and therapeutics.
- Current challenges in WGAS include multiple testing, study design, phenotype definition, and polymorphism interactions.
Conclusions:
- Whole-genome association studies hold significant promise for understanding the genetic basis of common diseases.
- Overcoming current challenges is essential for the successful application of WGAS.
- This approach is key to advancing diagnostics and therapeutics for conditions like type 2 diabetes and schizophrenia.

